SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007391
Filing Date
2016-08-04
Accepted
2016-08-04 16:07:04
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtae-20160630x10q.htm 10-Q 1628638
2 EX-10.33 vtae-20160630ex103392b15.htm EX-10.33 126553
3 EX-10.34 vtae-20160630ex103486ca7.htm EX-10.34 111266
4 EX-10.35 vtae-20160630ex103573e4c.htm EX-10.35 112794
5 EX-10.36 vtae-20160630ex10366b096.htm EX-10.36 108200
6 EX-10.37 vtae-20160630ex103796bfc.htm EX-10.37 107904
7 EX-10.38 vtae-20160630ex103822a71.htm EX-10.38 111161
8 EX-31.1 vtae-20160630ex3118d352e.htm EX-31.1 14560
9 EX-31.2 vtae-20160630ex312a6ae8c.htm EX-31.2 14223
10 EX-32.1 vtae-20160630ex321ca36c0.htm EX-32.1 13738
  Complete submission text file 0001558370-16-007391.txt   6101413

Data Files

Seq Description Document Type Size
11 EX-101.INS vtae-20160630.xml EX-101.INS 1038468
12 EX-101.SCH vtae-20160630.xsd EX-101.SCH 40939
13 EX-101.CAL vtae-20160630_cal.xml EX-101.CAL 47314
14 EX-101.DEF vtae-20160630_def.xml EX-101.DEF 142752
15 EX-101.LAB vtae-20160630_lab.xml EX-101.LAB 378286
16 EX-101.PRE vtae-20160630_pre.xml EX-101.PRE 283223
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36617 | Film No.: 161807432
SIC: 2834 Pharmaceutical Preparations